World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   34 records for 26 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3
Recruitment statusMain ID Public TitleDate of Registration
Not recruitingACTRN12614000262606
Ultrasound guided Transversus Abdominis Plane block: An evaluation of its efficacy in reducing post-op opioid requirements in Caesarean section
11/03/2014
Not recruitingACTRN12614000211662
Incidence of difficult tracheal intubation in bariatric surgery patients.
27/02/2014
RecruitingNCT01957631
Comparing Steroid Injections and Platelet Rich Plasma Injections in the Treatment of Plantar Fasciitis
30/09/2013
RecruitingCTRI/2013/09/004004
Study to assess effectiveness of indacaterol in COPD patients in real life settings
19-09-2013
Not recruitingNCT01925001
Phase 2 Study of MP4CO to Treat Vaso-occlusive Sickle Crisis
14/08/2013
RecruitingNCT01923909
Comparison of IA Platelet Rich Plasma Injections With IA Steroid Injections in Treatment of Primary Knee Osteoarthritis
13/08/2013
RecruitingNCT01800006
Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation in Latinamerica and EMEA Region
25/02/2013
Not recruitingACTRN12612000560897
Vitamin D therapy in patients with sickle cell disease (SCD)
25/05/2012
RecruitingNCT01562665
Epidemiological Study to Describe Non Small Cell Lung Cancer Clinical Management Patterns in MENA. Lung-EPICLIN/ Gulf
22/02/2012
AuthorisedEUCTR2011-005334-20-AT
A multicenter, open-label, single-arm study of pertuzumab in combination with trastuzumab and a taxane in first line treatment of patients with HER2- positive advanced (metastatic or locally recurrent) breast cancer
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2011-005334-20-ESA multicenter, open-label, single-arm study of pertuzumab in combination with trastuzumab and a taxane in first line treatment of patients with HER2- positive advanced (metastatic or locally recurrent) breast cancer22/02/2012
AuthorisedEUCTR2011-005334-20-SIA multicenter, open-label, single-arm study of pertuzumab in combination with trastuzumab and a taxane in first line treatment of patients with HER2- positive advanced (metastatic or locally recurrent) breast cancer27/02/2012
AuthorisedEUCTR2011-005334-20-HUA multicenter, open-label, single-arm study of pertuzumab in combination with trastuzumab and a taxane in first line treatment of patients with HER2- positive advanced (metastatic or locally recurrent) breast cancer21/03/2012
AuthorisedEUCTR2011-005334-20-GRA multicenter, open-label, single-arm study of pertuzumab in combination with trastuzumab and a taxane in first line treatment of patients with HER2- positive advanced (metastatic or locally recurrent) breast cancer11/04/2012
AuthorisedEUCTR2011-005334-20-ITA multicenter, open-label, single-arm study of pertuzumab in combination with trastuzumab and a taxane in first line treatment of patients with HER2- positive advanced (metastatic or locally recurrent) breast cancer02/08/2012
AuthorisedEUCTR2011-005334-20-DEA multicenter, open-label, single-arm study of pertuzumab in combination with trastuzumab and a taxane in first line treatment of patients with HER2- positive advanced (metastatic or locally recurrent) breast cancer07/03/2012
AuthorisedEUCTR2011-005334-20-EEA multicenter, open-label, single-arm study of pertuzumab in combination with trastuzumab and a taxane in first line treatment of patients with HER2- positive advanced (metastatic or locally recurrent) breast cancer08/03/2013
AuthorisedEUCTR2011-005334-20-PTA multicenter, open-label, single-arm study of pertuzumab in combination with trastuzumab and a taxane in first line treatment of patients with HER2- positive advanced (metastatic or locally recurrent) breast cancer03/04/2012
AuthorisedEUCTR2011-005334-20-LTA multicenter, open-label, single-arm study of pertuzumab in combination with trastuzumab and a taxane in first line treatment of patients with HER2- positive advanced (metastatic or locally recurrent) breast cancer18/06/2013
AuthorisedEUCTR2011-005334-20-NLA multicenter, open-label, single-arm study of pertuzumab in combination with trastuzumab and a taxane in first line treatment of patients with HER2- positive advanced (metastatic or locally recurrent) breast cancer05/03/2012
AuthorisedEUCTR2011-005334-20-PLA multicenter, open-label, single-arm study of pertuzumab in combination with trastuzumab and a taxane in first line treatment of patients with HER2- positive advanced (metastatic or locally recurrent) breast cancer02/07/2013
AuthorisedEUCTR2011-005334-20-BEA multicenter, open-label, single-arm study of pertuzumab in combination with trastuzumab and a taxane in first line treatment of patients with HER2- positive advanced (metastatic or locally recurrent) breast cancer13/03/2012
AuthorisedEUCTR2011-005334-20-GBA multicenter, open-label, single-arm study of pertuzumab in combination with trastuzumab and a taxane in first line treatment of patients with HER2- positive advanced (metastatic or locally recurrent) breast cancer01/03/2012
AuthorisedEUCTR2011-005334-20-SEA multicenter, open-label, single-arm study of pertuzumab in combination with trastuzumab and a taxane in first line treatment of patients with HER2- positive advanced (metastatic or locally recurrent) breast cancer15/05/2012
AuthorisedEUCTR2011-005334-20-FIA multicenter, open-label, single-arm study of pertuzumab in combination with trastuzumab and a taxane in first line treatment of patients with HER2- positive advanced (metastatic or locally recurrent) breast cancer27/01/2012
RecruitingNCT01572038A Study of Pertuzumab in Combination With Herceptin (Trastuzumab) and A Taxane in First-Line Treatment in Patients With HER2-Positive Advanced Breast Cancer (PERUSE)03/04/2012
16/01/2012
    
1 2 3
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history